EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

From soil to clinic: current advances in understanding Coccidioides and coccidioidomycosis

Katrina M Jackson, Marcus de Melo Teixeira, Bridget M Barker iD

Microbiology and Molecular Biology Reviews · 2024

DOI: 10.1128/mmbr.00161-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, 2024. Verfasst von Katrina M Jackson und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Coccidioides, Coccidioidomycosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coccidioides immitis and Coccidioides posadasii are fungal pathogens that cause systemic mycoses and are prevalent in arid regions in the Americas. While C. immitis mainly occurs in California and Washington, C. posadasii is widely distributed across North and South America. Both species induce coccidioidomycosis (San Joaquin Valley fever or, more commonly, Valley fever), with reported cases surging in the United States, notably in California and Arizona. Moreover, cases in Argentina, Brazil, and Mexico are on the rise. Climate change and environmental alterations conducive to Coccidioides spp. proliferation have been recently explored. Diagnostic challenges contribute to delayed treatment initiation, compounded by limited therapeutic options. Although antifungal drugs are often effective treatments, some patients do not respond to current therapies, underscoring the urgent need for a vaccine, particularly for vulnerable populations over 60 years old relocating to endemic areas. Despite recent progress, gaps persist in the understanding of Coccidioides ecology, host immune responses, and vaccine development. This review synthesizes recent research advancements in Coccidioides ecology, genomics, and immune responses, emphasizing ongoing efforts to develop a human vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCoccidioidesCoccidioidomycosisHumansClimate ChangeFungal VaccinesSoil Microbiology

Stichwörter der Autor:innen

Coccidioidescoccidioidomycosisfungal diseasemedical mycologyvalley fever

Substanzen

Antifungal AgentsFungal Vaccines

Autor:innen und Institutionen

  • The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.
  • Faculty of Medicine, University of Brasília, Brasília-DF, Brasília, Brazil.
  • Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA.

ORCID-Profile: Bridget M Barker

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS

Zitieren

APA

Jackson, K. M., Teixeira, M. M., & Barker, B. M. (2024). From soil to clinic: current advances in understanding Coccidioides and coccidioidomycosis. Microbiology and Molecular Biology Reviews. https://doi.org/10.1128/mmbr.00161-23

Vancouver

Jackson KM, Teixeira MM, Barker BM. From soil to clinic: current advances in understanding Coccidioides and coccidioidomycosis. Microbiology and Molecular Biology Reviews. 2024. doi:10.1128/mmbr.00161-23

BibTeX
@article{Jackson2024,
  author = {Jackson, Katrina M and Teixeira, Marcus de Melo and Barker, Bridget M},
  title = {From soil to clinic: current advances in understanding Coccidioides and coccidioidomycosis},
  journal = {Microbiology and Molecular Biology Reviews},
  year = {2024},
  doi = {10.1128/mmbr.00161-23}
}
Kostenlos starten →